Michael Hiltzik, Los Angeles Times; Column: COVID-19 could kill the for-profit science publishing model. That would be a good thing
"The current crisis has demonstrated the value of open access to research, as well as the drawbacks of secrecy."
The Ebook version of my Bloomsbury book "Ethics, Information, and Technology" will be published on December 11, 2025 and the Hardback and Paperback versions will be available on January 8, 2026; Preorders are available via this webpage: https://www.bloomsbury.com/us/ethics-information-and-technology-9781440856662/
Showing posts with label coronaviruses. Show all posts
Showing posts with label coronaviruses. Show all posts
Thursday, March 5, 2020
Friday, February 7, 2020
Chinese scientists ask for patent on US drug to fight virus; Associated Press, February 6, 2020
Joe McDonald and Linda A. Johnson, Associated Press; Chinese scientists ask for patent on US drug to fight virus
"China has the right
under World Trade Organization rules to declare an emergency and compel a
company to license a patent to protect the public. It would be required
to pay a license fee that is deemed fair market value.
The
government might be able to avoid that fee if the patent were granted
to the Wuhan institute, part of the elite Chinese Academy of Sciences.
The
institute said it applied for a “use patent” that specifies the Wuhan
virus as the drug’s target. Gilead’s patent application, filed before
the virus was identified, cites only the overall family of
coronaviruses."
Subscribe to:
Posts (Atom)